Clinical Trials Unit
Stanford University School of Medicine's Center for Advanced Dermatologic Investigation is the Dermatology Department's clinical trials unit.
The Center is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications. The Center works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments. New studies begin regularly, and the Center continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.
Skin Aging Studies
We seek to understand the human aging processes as it relates to skin on a fundamental level. To this end, our studies focus on clinical and translational research efforts ranging from: (1) the analysis of gene changes which predispose individuals to exceptionally youthful skin to (2) molecular signatures that may be biomarkers for aging skin to (3) the careful study of new candidate agents which might affect the skin aging process.
Nonmelanoma Skin Cancer
Recent advances in our understanding of basal cell skin cancer biology have enabled the development of cutting edge study drugs which combat tumor growth. We are currently home to a number of clinical trials at the forefront of potential therapy for advanced or metastatic basal cell cancer. In addition, we seek to understand the biology of basal cell skin cancers and to identify molecular predictors for treatment success.
Acne Rosecea
This is a common and frustrating chronic inflammatory condition of the face, usually affecting older individuals. The causes of this complex condition are the subject of much study. Our clinical studies seek to identify new topical or oral medications to improve the symptoms of acne rosacea.
Contact
For more information, please email dermtrials@stanford.edu
Featured Clinical Trials
A Community Health Worker-Led LSSS Intervention in Bangladesh
The sodium found in salt is a powerful cause of high blood pressure, and most sodium ingested by humans is from their diet. High blood pressure is known to cause heart attacks and strokes, so various public health programs have attempted to find ways for people to reduce their salt intake to avoid these complications. These programs, however, have proven challenging, as asking people to alter their food preparation practices is often met with resistance. As such, we wish to test the blood pressure-lowering effects of low sodium salt substitute (LSSS), a salt substance in which a third of the compound by weight is composed of potassium (which does not increase blood pressure) rather than sodium. Additionally, the best way of supplying LSSS to people is yet unknown. We thus propose to study the effectiveness of an LSSS product by directly providing it via community health workers in 309 households in rural Bangladesh.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- dietary supplement: Low-Sodium Salt Substitute
- behavioral: Information/Education
Eligibility
Inclusion Criteria:
- Our target population is that of adults living in rural Bangladesh, while our study
population will be comprised of adults (age ≥18 years old) living in Parbatipur, a
rural/semi-rural sub-district in Dinajpur District (Rangpur Division), in the north of
the country. Within Parbatipur, BRAC University has assessed 700 households for NCD
risk factors as part of a larger Wellcome-trust funded multinational biobank
(involving those living in Bangladesh, India, Pakistan, and Sri Lanka) to better
understand the patterns and determinants of cardiovascular health in South Asian
people in a cross-sectional analysis. All adults living in these surveyed households
will be eligible to participate.
Exclusion Criteria:
- Exclusion criteria include subjects taking potassium-sparing diuretics, already taking
potassium supplements, or those who have known kidney disease at baseline.
- All adults initially screened for intervention will undergo serum creatinine testing,
with those with values >106 mMol/L for males and >97 mMol/L for female excluded from
the intervention but kept in the intervention group by intention-to-treat principles
to avoid breaking of randomization.
- Although minors will not be involved in the study, to avoid spillover injury to
children in the intervention households, all members of intervention households under
the age of 18 will also undergo urine dipstick testing. If proteinuria is detected,
the household will be excluded from receiving the LSSS intervention (but followed in
the intervention arm to avoid breaking randomization).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Animesh Talukder, MPH
+880 1670427812
I'm interested
Psoriasis Clinical Trials
A Community Health Worker-Led LSSS Intervention in Bangladesh
The sodium found in salt is a powerful cause of high blood pressure, and most sodium ingested by humans is from their diet. High blood pressure is known to cause heart attacks and strokes, so various public health programs have attempted to find ways for people to reduce their salt intake to avoid these complications. These programs, however, have proven challenging, as asking people to alter their food preparation practices is often met with resistance. As such, we wish to test the blood pressure-lowering effects of low sodium salt substitute (LSSS), a salt substance in which a third of the compound by weight is composed of potassium (which does not increase blood pressure) rather than sodium. Additionally, the best way of supplying LSSS to people is yet unknown. We thus propose to study the effectiveness of an LSSS product by directly providing it via community health workers in 309 households in rural Bangladesh.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- dietary supplement: Low-Sodium Salt Substitute
- behavioral: Information/Education
Eligibility
Inclusion Criteria:
- Our target population is that of adults living in rural Bangladesh, while our study
population will be comprised of adults (age ≥18 years old) living in Parbatipur, a
rural/semi-rural sub-district in Dinajpur District (Rangpur Division), in the north of
the country. Within Parbatipur, BRAC University has assessed 700 households for NCD
risk factors as part of a larger Wellcome-trust funded multinational biobank
(involving those living in Bangladesh, India, Pakistan, and Sri Lanka) to better
understand the patterns and determinants of cardiovascular health in South Asian
people in a cross-sectional analysis. All adults living in these surveyed households
will be eligible to participate.
Exclusion Criteria:
- Exclusion criteria include subjects taking potassium-sparing diuretics, already taking
potassium supplements, or those who have known kidney disease at baseline.
- All adults initially screened for intervention will undergo serum creatinine testing,
with those with values >106 mMol/L for males and >97 mMol/L for female excluded from
the intervention but kept in the intervention group by intention-to-treat principles
to avoid breaking of randomization.
- Although minors will not be involved in the study, to avoid spillover injury to
children in the intervention households, all members of intervention households under
the age of 18 will also undergo urine dipstick testing. If proteinuria is detected,
the household will be excluded from receiving the LSSS intervention (but followed in
the intervention arm to avoid breaking randomization).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Animesh Talukder, MPH
+880 1670427812
I'm interested
Dermatology Clinical Trials
A Community Health Worker-Led LSSS Intervention in Bangladesh
The sodium found in salt is a powerful cause of high blood pressure, and most sodium ingested by humans is from their diet. High blood pressure is known to cause heart attacks and strokes, so various public health programs have attempted to find ways for people to reduce their salt intake to avoid these complications. These programs, however, have proven challenging, as asking people to alter their food preparation practices is often met with resistance. As such, we wish to test the blood pressure-lowering effects of low sodium salt substitute (LSSS), a salt substance in which a third of the compound by weight is composed of potassium (which does not increase blood pressure) rather than sodium. Additionally, the best way of supplying LSSS to people is yet unknown. We thus propose to study the effectiveness of an LSSS product by directly providing it via community health workers in 309 households in rural Bangladesh.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- dietary supplement: Low-Sodium Salt Substitute
- behavioral: Information/Education
Eligibility
Inclusion Criteria:
- Our target population is that of adults living in rural Bangladesh, while our study
population will be comprised of adults (age ≥18 years old) living in Parbatipur, a
rural/semi-rural sub-district in Dinajpur District (Rangpur Division), in the north of
the country. Within Parbatipur, BRAC University has assessed 700 households for NCD
risk factors as part of a larger Wellcome-trust funded multinational biobank
(involving those living in Bangladesh, India, Pakistan, and Sri Lanka) to better
understand the patterns and determinants of cardiovascular health in South Asian
people in a cross-sectional analysis. All adults living in these surveyed households
will be eligible to participate.
Exclusion Criteria:
- Exclusion criteria include subjects taking potassium-sparing diuretics, already taking
potassium supplements, or those who have known kidney disease at baseline.
- All adults initially screened for intervention will undergo serum creatinine testing,
with those with values >106 mMol/L for males and >97 mMol/L for female excluded from
the intervention but kept in the intervention group by intention-to-treat principles
to avoid breaking of randomization.
- Although minors will not be involved in the study, to avoid spillover injury to
children in the intervention households, all members of intervention households under
the age of 18 will also undergo urine dipstick testing. If proteinuria is detected,
the household will be excluded from receiving the LSSS intervention (but followed in
the intervention arm to avoid breaking randomization).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Animesh Talukder, MPH
+880 1670427812
I'm interested
Pediatric Dermatology Clinical Trials
A Community Health Worker-Led LSSS Intervention in Bangladesh
The sodium found in salt is a powerful cause of high blood pressure, and most sodium ingested by humans is from their diet. High blood pressure is known to cause heart attacks and strokes, so various public health programs have attempted to find ways for people to reduce their salt intake to avoid these complications. These programs, however, have proven challenging, as asking people to alter their food preparation practices is often met with resistance. As such, we wish to test the blood pressure-lowering effects of low sodium salt substitute (LSSS), a salt substance in which a third of the compound by weight is composed of potassium (which does not increase blood pressure) rather than sodium. Additionally, the best way of supplying LSSS to people is yet unknown. We thus propose to study the effectiveness of an LSSS product by directly providing it via community health workers in 309 households in rural Bangladesh.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- dietary supplement: Low-Sodium Salt Substitute
- behavioral: Information/Education
Eligibility
Inclusion Criteria:
- Our target population is that of adults living in rural Bangladesh, while our study
population will be comprised of adults (age ≥18 years old) living in Parbatipur, a
rural/semi-rural sub-district in Dinajpur District (Rangpur Division), in the north of
the country. Within Parbatipur, BRAC University has assessed 700 households for NCD
risk factors as part of a larger Wellcome-trust funded multinational biobank
(involving those living in Bangladesh, India, Pakistan, and Sri Lanka) to better
understand the patterns and determinants of cardiovascular health in South Asian
people in a cross-sectional analysis. All adults living in these surveyed households
will be eligible to participate.
Exclusion Criteria:
- Exclusion criteria include subjects taking potassium-sparing diuretics, already taking
potassium supplements, or those who have known kidney disease at baseline.
- All adults initially screened for intervention will undergo serum creatinine testing,
with those with values >106 mMol/L for males and >97 mMol/L for female excluded from
the intervention but kept in the intervention group by intention-to-treat principles
to avoid breaking of randomization.
- Although minors will not be involved in the study, to avoid spillover injury to
children in the intervention households, all members of intervention households under
the age of 18 will also undergo urine dipstick testing. If proteinuria is detected,
the household will be excluded from receiving the LSSS intervention (but followed in
the intervention arm to avoid breaking randomization).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Animesh Talukder, MPH
+880 1670427812
I'm interested
A Community Health Worker-Led LSSS Intervention in Bangladesh
The sodium found in salt is a powerful cause of high blood pressure, and most sodium ingested by humans is from their diet. High blood pressure is known to cause heart attacks and strokes, so various public health programs have attempted to find ways for people to reduce their salt intake to avoid these complications. These programs, however, have proven challenging, as asking people to alter their food preparation practices is often met with resistance. As such, we wish to test the blood pressure-lowering effects of low sodium salt substitute (LSSS), a salt substance in which a third of the compound by weight is composed of potassium (which does not increase blood pressure) rather than sodium. Additionally, the best way of supplying LSSS to people is yet unknown. We thus propose to study the effectiveness of an LSSS product by directly providing it via community health workers in 309 households in rural Bangladesh.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- dietary supplement: Low-Sodium Salt Substitute
- behavioral: Information/Education
Eligibility
Inclusion Criteria:
- Our target population is that of adults living in rural Bangladesh, while our study
population will be comprised of adults (age ≥18 years old) living in Parbatipur, a
rural/semi-rural sub-district in Dinajpur District (Rangpur Division), in the north of
the country. Within Parbatipur, BRAC University has assessed 700 households for NCD
risk factors as part of a larger Wellcome-trust funded multinational biobank
(involving those living in Bangladesh, India, Pakistan, and Sri Lanka) to better
understand the patterns and determinants of cardiovascular health in South Asian
people in a cross-sectional analysis. All adults living in these surveyed households
will be eligible to participate.
Exclusion Criteria:
- Exclusion criteria include subjects taking potassium-sparing diuretics, already taking
potassium supplements, or those who have known kidney disease at baseline.
- All adults initially screened for intervention will undergo serum creatinine testing,
with those with values >106 mMol/L for males and >97 mMol/L for female excluded from
the intervention but kept in the intervention group by intention-to-treat principles
to avoid breaking of randomization.
- Although minors will not be involved in the study, to avoid spillover injury to
children in the intervention households, all members of intervention households under
the age of 18 will also undergo urine dipstick testing. If proteinuria is detected,
the household will be excluded from receiving the LSSS intervention (but followed in
the intervention arm to avoid breaking randomization).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Animesh Talukder, MPH
+880 1670427812
I'm interested
A Community Health Worker-Led LSSS Intervention in Bangladesh
The sodium found in salt is a powerful cause of high blood pressure, and most sodium ingested by humans is from their diet. High blood pressure is known to cause heart attacks and strokes, so various public health programs have attempted to find ways for people to reduce their salt intake to avoid these complications. These programs, however, have proven challenging, as asking people to alter their food preparation practices is often met with resistance. As such, we wish to test the blood pressure-lowering effects of low sodium salt substitute (LSSS), a salt substance in which a third of the compound by weight is composed of potassium (which does not increase blood pressure) rather than sodium. Additionally, the best way of supplying LSSS to people is yet unknown. We thus propose to study the effectiveness of an LSSS product by directly providing it via community health workers in 309 households in rural Bangladesh.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- dietary supplement: Low-Sodium Salt Substitute
- behavioral: Information/Education
Eligibility
Inclusion Criteria:
- Our target population is that of adults living in rural Bangladesh, while our study
population will be comprised of adults (age ≥18 years old) living in Parbatipur, a
rural/semi-rural sub-district in Dinajpur District (Rangpur Division), in the north of
the country. Within Parbatipur, BRAC University has assessed 700 households for NCD
risk factors as part of a larger Wellcome-trust funded multinational biobank
(involving those living in Bangladesh, India, Pakistan, and Sri Lanka) to better
understand the patterns and determinants of cardiovascular health in South Asian
people in a cross-sectional analysis. All adults living in these surveyed households
will be eligible to participate.
Exclusion Criteria:
- Exclusion criteria include subjects taking potassium-sparing diuretics, already taking
potassium supplements, or those who have known kidney disease at baseline.
- All adults initially screened for intervention will undergo serum creatinine testing,
with those with values >106 mMol/L for males and >97 mMol/L for female excluded from
the intervention but kept in the intervention group by intention-to-treat principles
to avoid breaking of randomization.
- Although minors will not be involved in the study, to avoid spillover injury to
children in the intervention households, all members of intervention households under
the age of 18 will also undergo urine dipstick testing. If proteinuria is detected,
the household will be excluded from receiving the LSSS intervention (but followed in
the intervention arm to avoid breaking randomization).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Animesh Talukder, MPH
+880 1670427812
I'm interested